The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 217 participants.
Also called NCT02231788
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 217 participants
- Registry
-
NCT02231788
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02231788. Randomized; no masking; primary purpose treatment. Start 2014-06 (actual); primary completion 2018-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy
- Acronym
- TENUVA-BP
- Condition
- Hypertension
- Intervention (Drug)
- Telminuvo®Tab. 40/2.5mg
- Intervention (Drug)
- Telmitrend®Tab. 80mg
- Lead sponsor
- Chong Kun Dang Pharmaceutical
Record details
- Record id
cardio:ct-nct02231788- Content hash
81f43bc92e90683e0be71c80203dd7ab3036d897707b49721c604d294125add3